Discovery of Novel Indoleamine 2,3-Dioxygenase 1 (IDO1) and Histone Deacetylase (HDAC) Dual Inhibitors

DOI: 10.1021/acsmedchemlett.7b00487

Keywords: IDO1, HDAC, dual inhibitors, cancer immunotherapy, epigenetics, antitumor efficacy

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text